APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hirudin

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Selected research

Market Analysis & Forecast

Global Hirudin Market Analysis and Forecast 2026-2032

Report ID 17328735021 January 2026208 pages

Choose your research edition.

Industry ResearchHirudin Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Hirudin Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Hirudin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hirudin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hirudin Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

This report presents an overview of global market for Hirudin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Hirudin, also provides the consumption of main regions and countries. Of the upcoming market potential for Hirudin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hirudin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hirudin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hirudin sales, projected growth trends, production technology, application and end-user industry.

Hirudin Segment by Company

The Medicines Company

Keyken

Minapharm

Abbott

SALUBRIS

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

DUOPUTAI

Pentapharm

Hirudin Segment by Type

Natural Hirudin

Recombinant Hirudin

Hirudin Segment by Application

Thrombosis Disease

Tumor Disease

Others

Hirudin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hirudin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hirudin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hirudin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Hirudin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Hirudin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hirudin sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hirudin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Natural Hirudin Major Manufacturers Table 3. Recombinant Hirudin Major Manufacturers Table 4. Global Hirudin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Thrombosis Disease Major Manufacturers Table 6. Tumor Disease Major Manufacturers Table 7. Others Major Manufacturers Table 8. Hirudin Industry Trends Table 9. Hirudin Industry Drivers Table 10. Hirudin Industry Opportunities and Challenges Table 11. Hirudin Industry Restraints Table 12. Global Hirudin Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (MT) Table 13. Global Hirudin Production by Region (2021-2026) & (MT) Table 14. Global Hirudin Production by Region (2027-2032) & (MT) Table 15. Global Hirudin Production Market Share by Region (2021-2026) Table 16. Global Hirudin Production Market Share by Region (2027-2032) Table 17. Global Hirudin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Hirudin Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Hirudin Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Hirudin Revenue Market Share by Region (2021-2026) Table 21. Global Hirudin Revenue Market Share by Region (2027-2032) Table 22. Global Hirudin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (MT) Table 23. Global Hirudin Sales by Region (2021-2026) & (MT) Table 24. Global Hirudin Sales by Region (2027-2032) & (MT) Table 25. Global Hirudin Sales Market Share by Region (2021-2026) Table 26. Global Hirudin Sales Market Share by Region (2027-2032) Table 27. Global Hirudin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Hirudin Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Hirudin Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Hirudin Sales Market Share by Manufacturers (2021-2026) Table 31. Global Hirudin Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 32. Global Hirudin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Hirudin Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Hirudin Manufacturers, Product Type & Application Table 35. Global Hirudin Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Hirudin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global Hirudin Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Hirudin Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Hirudin Revenue Market Share by Type (2021-2026) Table 41. Global Hirudin Revenue Market Share by Type (2027-2032) Table 42. Global Hirudin Sales by Type (2021-2026) & (MT) Table 43. Global Hirudin Sales by Type (2027-2032) & (MT) Table 44. Global Hirudin Sales Market Share by Type (2021-2026) Table 45. Global Hirudin Sales Market Share by Type (2027-2032) Table 46. Global Hirudin Price by Type (2021-2026) & (USD/Kg) Table 47. Global Hirudin Price by Type (2027-2032) & (USD/Kg) Table 48. Global Hirudin Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Hirudin Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Hirudin Revenue Market Share by Application (2021-2026) Table 51. Global Hirudin Revenue Market Share by Application (2027-2032) Table 52. Global Hirudin Sales by Application (2021-2026) & (MT) Table 53. Global Hirudin Sales by Application (2027-2032) & (MT) Table 54. Global Hirudin Sales Market Share by Application (2021-2026) Table 55. Global Hirudin Sales Market Share by Application (2027-2032) Table 56. Global Hirudin Price by Application (2021-2026) & (USD/Kg) Table 57. Global Hirudin Price by Application (2027-2032) & (USD/Kg) Table 58. The Medicines Company Company Information Table 59. The Medicines Company Business Overview Table 60. The Medicines Company Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 61. The Medicines Company Hirudin Product Portfolio Table 62. The Medicines Company Recent Development Table 63. Keyken Company Information Table 64. Keyken Business Overview Table 65. Keyken Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 66. Keyken Hirudin Product Portfolio Table 67. Keyken Recent Development Table 68. Minapharm Company Information Table 69. Minapharm Business Overview Table 70. Minapharm Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 71. Minapharm Hirudin Product Portfolio Table 72. Minapharm Recent Development Table 73. Abbott Company Information Table 74. Abbott Business Overview Table 75. Abbott Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 76. Abbott Hirudin Product Portfolio Table 77. Abbott Recent Development Table 78. SALUBRIS Company Information Table 79. SALUBRIS Business Overview Table 80. SALUBRIS Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 81. SALUBRIS Hirudin Product Portfolio Table 82. SALUBRIS Recent Development Table 83. Pfizer, Inc Company Information Table 84. Pfizer, Inc Business Overview Table 85. Pfizer, Inc Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 86. Pfizer, Inc Hirudin Product Portfolio Table 87. Pfizer, Inc Recent Development Table 88. Teva Pharmaceutical Industries Ltd Company Information Table 89. Teva Pharmaceutical Industries Ltd Business Overview Table 90. Teva Pharmaceutical Industries Ltd Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 91. Teva Pharmaceutical Industries Ltd Hirudin Product Portfolio Table 92. Teva Pharmaceutical Industries Ltd Recent Development Table 93. DUOPUTAI Company Information Table 94. DUOPUTAI Business Overview Table 95. DUOPUTAI Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 96. DUOPUTAI Hirudin Product Portfolio Table 97. DUOPUTAI Recent Development Table 98. Pentapharm Company Information Table 99. Pentapharm Business Overview Table 100. Pentapharm Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 101. Pentapharm Hirudin Product Portfolio Table 102. Pentapharm Recent Development Table 103. North America Hirudin Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Hirudin Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Hirudin Sales by Type (2021-2026) & (MT) Table 106. North America Hirudin Sales by Type (2027-2032) & (MT) Table 107. North America Hirudin Sales Price by Type (2021-2026) & (USD/Kg) Table 108. North America Hirudin Sales Price by Type (2027-2032) & (USD/Kg) Table 109. North America Hirudin Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Hirudin Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Hirudin Sales by Application (2021-2026) & (MT) Table 112. North America Hirudin Sales by Application (2027-2032) & (MT) Table 113. North America Hirudin Sales Price by Application (2021-2026) & (USD/Kg) Table 114. North America Hirudin Sales Price by Application (2027-2032) & (USD/Kg) Table 115. North America Hirudin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Hirudin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Hirudin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Hirudin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 119. North America Hirudin Sales by Country (2021-2026) & (MT) Table 120. North America Hirudin Sales by Country (2027-2032) & (MT) Table 121. North America Hirudin Sales Price by Country (2021-2026) & (USD/Kg) Table 122. North America Hirudin Sales Price by Country (2027-2032) & (USD/Kg) Table 123. United States Hirudin Revenue (2021-2032) & (US$ Million) Table 124. Canada Hirudin Revenue (2021-2032) & (US$ Million) Table 125. Mexico Hirudin Revenue (2021-2032) & (US$ Million) Table 126. Europe Hirudin Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Hirudin Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Hirudin Sales by Type (2021-2026) & (MT) Table 129. Europe Hirudin Sales by Type (2027-2032) & (MT) Table 130. Europe Hirudin Sales Price by Type (2021-2026) & (USD/Kg) Table 131. Europe Hirudin Sales Price by Type (2027-2032) & (USD/Kg) Table 132. Europe Hirudin Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Hirudin Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Hirudin Sales by Application (2021-2026) & (MT) Table 135. Europe Hirudin Sales by Application (2027-2032) & (MT) Table 136. Europe Hirudin Sales Price by Application (2021-2026) & (USD/Kg) Table 137. Europe Hirudin Sales Price by Application (2027-2032) & (USD/Kg) Table 138. Europe Hirudin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Hirudin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Hirudin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Hirudin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 142. Europe Hirudin Sales by Country (2021-2026) & (MT) Table 143. Europe Hirudin Sales by Country (2027-2032) & (MT) Table 144. Europe Hirudin Sales Price by Country (2021-2026) & (USD/Kg) Table 145. Europe Hirudin Sales Price by Country (2027-2032) & (USD/Kg) Table 146. Germany Hirudin Revenue (2021-2032) & (US$ Million) Table 147. France Hirudin Revenue (2021-2032) & (US$ Million) Table 148. U.K. Hirudin Revenue (2021-2032) & (US$ Million) Table 149. Italy Hirudin Revenue (2021-2032) & (US$ Million) Table 150. Russia Hirudin Revenue (2021-2032) & (US$ Million) Table 151. Spain Hirudin Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Hirudin Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Hirudin Revenue (2021-2032) & (US$ Million) Table 154. Sweden Hirudin Revenue (2021-2032) & (US$ Million) Table 155. Poland Hirudin Revenue (2021-2032) & (US$ Million) Table 156. China Hirudin Revenue by Type (2021-2026) & (US$ Million) Table 157. China Hirudin Revenue by Type (2027-2032) & (US$ Million) Table 158. China Hirudin Sales by Type (2021-2026) & (MT) Table 159. China Hirudin Sales by Type (2027-2032) & (MT) Table 160. China Hirudin Sales Price by Type (2021-2026) & (USD/Kg) Table 161. China Hirudin Sales Price by Type (2027-2032) & (USD/Kg) Table 162. China Hirudin Revenue by Application (2021-2026) & (US$ Million) Table 163. China Hirudin Revenue by Application (2027-2032) & (US$ Million) Table 164. China Hirudin Sales by Application (2021-2026) & (MT) Table 165. China Hirudin Sales by Application (2027-2032) & (MT) Table 166. China Hirudin Sales Price by Application (2021-2026) & (USD/Kg) Table 167. China Hirudin Sales Price by Application (2027-2032) & (USD/Kg) Table 168. Asia Hirudin Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Hirudin Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Hirudin Sales by Type (2021-2026) & (MT) Table 171. Asia Hirudin Sales by Type (2027-2032) & (MT) Table 172. Asia Hirudin Sales Price by Type (2021-2026) & (USD/Kg) Table 173. Asia Hirudin Sales Price by Type (2027-2032) & (USD/Kg) Table 174. Asia Hirudin Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Hirudin Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Hirudin Sales by Application (2021-2026) & (MT) Table 177. Asia Hirudin Sales by Application (2027-2032) & (MT) Table 178. Asia Hirudin Sales Price by Application (2021-2026) & (USD/Kg) Table 179. Asia Hirudin Sales Price by Application (2027-2032) & (USD/Kg) Table 180. Asia Hirudin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Hirudin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Hirudin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Hirudin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 184. Asia Hirudin Sales by Country (2021-2026) & (MT) Table 185. Asia Hirudin Sales by Country (2027-2032) & (MT) Table 186. Asia Hirudin Sales Price by Country (2021-2026) & (USD/Kg) Table 187. Asia Hirudin Sales Price by Country (2027-2032) & (USD/Kg) Table 188. Japan Hirudin Revenue (2021-2032) & (US$ Million) Table 189. South Korea Hirudin Revenue (2021-2032) & (US$ Million) Table 190. India Hirudin Revenue (2021-2032) & (US$ Million) Table 191. Australia Hirudin Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Hirudin Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Hirudin Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Hirudin Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Hirudin Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Hirudin Sales by Type (2021-2026) & (MT) Table 197. SAMEA Hirudin Sales by Type (2027-2032) & (MT) Table 198. SAMEA Hirudin Sales Price by Type (2021-2026) & (USD/Kg) Table 199. SAMEA Hirudin Sales Price by Type (2027-2032) & (USD/Kg) Table 200. SAMEA Hirudin Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Hirudin Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Hirudin Sales by Application (2021-2026) & (MT) Table 203. SAMEA Hirudin Sales by Application (2027-2032) & (MT) Table 204. SAMEA Hirudin Sales Price by Application (2021-2026) & (USD/Kg) Table 205. SAMEA Hirudin Sales Price by Application (2027-2032) & (USD/Kg) Table 206. SAMEA Hirudin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Hirudin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Hirudin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Hirudin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 210. SAMEA Hirudin Sales by Country (2021-2026) & (MT) Table 211. SAMEA Hirudin Sales by Country (2027-2032) & (MT) Table 212. SAMEA Hirudin Sales Price by Country (2021-2026) & (USD/Kg) Table 213. SAMEA Hirudin Sales Price by Country (2027-2032) & (USD/Kg) Table 214. Brazil Hirudin Revenue (2021-2032) & (US$ Million) Table 215. Argentina Hirudin Revenue (2021-2032) & (US$ Million) Table 216. Chile Hirudin Revenue (2021-2032) & (US$ Million) Table 217. Colombia Hirudin Revenue (2021-2032) & (US$ Million) Table 218. Peru Hirudin Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Hirudin Revenue (2021-2032) & (US$ Million) Table 220. Israel Hirudin Revenue (2021-2032) & (US$ Million) Table 221. UAE Hirudin Revenue (2021-2032) & (US$ Million) Table 222. Turkey Hirudin Revenue (2021-2032) & (US$ Million) Table 223. Iran Hirudin Revenue (2021-2032) & (US$ Million) Table 224. Egypt Hirudin Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Hirudin Distributors List Table 228. Hirudin Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Hirudin Product Image Figure 2. Global Hirudin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hirudin Market Size Share 2021 VS 2025 VS 2032 Figure . Natural Hirudin Image Figure 1. Recombinant Hirudin Image Figure 2. Global Hirudin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hirudin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Thrombosis Disease Image Figure 5. Tumor Disease Image Figure 6. Others Image Figure 7. Global Hirudin Capacity, Capacity Utilization (2021-2032) & (MT) Figure 8. Global Hirudin Production by Region: 2021 VS 2025 VS 2032 (MT) Figure 9. Global Hirudin Production Market Share by Region: 2025 Versus 2032 Figure 10. Global Hirudin Production Market Share by Region (2021-2032) Figure 11. North America Hirudin Production Growth Rate (2021-2032) & (MT) Figure 12. Europe Hirudin Production Growth Rate (2021-2032) & (MT) Figure 13. China Hirudin Production Growth Rate (2021-2032) & (MT) Figure 14. Japan Hirudin Production Growth Rate (2021-2032) & (MT) Figure 15. Global Hirudin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Hirudin Revenue (2021-2032) & (US$ Million) Figure 17. Global Hirudin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Hirudin Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Hirudin Revenue Market Share by Region (2021-2032) Figure 20. Global Hirudin Sales (2021-2032) & (MT) Figure 21. Global Hirudin Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 22. Global Hirudin Sales Market Share by Region (2021-2032) Figure 23. North America Hirudin Sales YoY (2021-2032) & (MT) Figure 24. Europe Hirudin Sales YoY (2021-2032) & (MT) Figure 25. China Hirudin Sales YoY (2021-2032) & (MT) Figure 26. Asia (Excluding China) Hirudin Sales YoY (2021-2032) & (MT) Figure 27. South America, Middle East and Africa Hirudin Sales YoY (2021-2032) & (MT) Figure 28. Global Hirudin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Hirudin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Hirudin Revenue Market Share by Type (2021-2032) Figure 32. Global Hirudin Sales Market Share by Type (2021-2032) Figure 33. Global Hirudin Revenue Market Share by Application (2021-2032) Figure 34. Global Hirudin Sales Market Share by Application (2021-2032) Figure 35. North America Hirudin Revenue Share by Type (2021-2032) Figure 36. North America Hirudin Sales Share by Type (2021-2032) Figure 37. North America Hirudin Revenue Share by Application (2021-2032) Figure 38. North America Hirudin Sales Share by Application (2021-2032) Figure 39. North America Hirudin Revenue Share by Country (2021-2032) Figure 40. North America Hirudin Sales Share by Country (2021-2032) Figure 41. Europe Hirudin Revenue Share by Type (2021-2032) Figure 42. Europe Hirudin Sales Share by Type (2021-2032) Figure 43. Europe Hirudin Revenue Share by Application (2021-2032) Figure 44. Europe Hirudin Sales Share by Application (2021-2032) Figure 45. Europe Hirudin Revenue Share by Country (2021-2032) Figure 46. Europe Hirudin Sales Share by Country (2021-2032) Figure 47. China Hirudin Revenue Share by Type (2021-2032) Figure 48. China Hirudin Sales Share by Type (2021-2032) Figure 49. China Hirudin Revenue Share by Application (2021-2032) Figure 50. China Hirudin Sales Share by Application (2021-2032) Figure 51. Asia Hirudin Revenue Share by Type (2021-2032) Figure 52. Asia Hirudin Sales Share by Type (2021-2032) Figure 53. Asia Hirudin Revenue Share by Application (2021-2032) Figure 54. Asia Hirudin Sales Share by Application (2021-2032) Figure 55. Asia Hirudin Revenue Share by Country (2021-2032) Figure 56. Asia Hirudin Sales Share by Country (2021-2032) Figure 57. SAMEA Hirudin Revenue Share by Type (2021-2032) Figure 58. SAMEA Hirudin Sales Share by Type (2021-2032) Figure 59. SAMEA Hirudin Revenue Share by Application (2021-2032) Figure 60. SAMEA Hirudin Sales Share by Application (2021-2032) Figure 61. SAMEA Hirudin Revenue Share by Country (2021-2032) Figure 62. SAMEA Hirudin Sales Share by Country (2021-2032) Figure 63. Hirudin Value Chain Figure 64. Manufacturing Cost Structure Figure 65. Hirudin Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Hirudin
  • Recombinant Hirudin
Applications
  • Thrombosis Disease
  • Tumor Disease
  • Others
Companies covered
  • The Medicines Company
  • Keyken
  • Minapharm
  • Abbott
  • SALUBRIS
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • DUOPUTAI
  • Pentapharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hirudin Market by Type
  3. 1.2.1 Global Hirudin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Natural Hirudin
  5. 1.2.3 Recombinant Hirudin
  6. 1.3 Hirudin Market by Application
  7. 1.3.1 Global Hirudin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Thrombosis Disease
  9. 1.3.3 Tumor Disease
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Hirudin Market Dynamics
  1. 2.1 Hirudin Industry Trends
  2. 2.2 Hirudin Industry Drivers
  3. 2.3 Hirudin Industry Opportunities and Challenges
  4. 2.4 Hirudin Industry Restraints
3 Global Hirudin Production Overview
  1. 3.1 Global Hirudin Production Capacity (2021-2032)
  2. 3.2 Global Hirudin Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Hirudin Production by Region
  4. 3.3.1 Global Hirudin Production by Region (2021-2026)
  5. 3.3.2 Global Hirudin Production by Region (2027-2032)
  6. 3.3.3 Global Hirudin Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Hirudin Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Hirudin Revenue by Region
  3. 4.2.1 Global Hirudin Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Hirudin Revenue by Region (2021-2026)
  5. 4.2.3 Global Hirudin Revenue by Region (2027-2032)
  6. 4.2.4 Global Hirudin Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Hirudin Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Hirudin Sales by Region
  9. 4.4.1 Global Hirudin Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Hirudin Sales by Region (2021-2026)
  11. 4.4.3 Global Hirudin Sales by Region (2027-2032)
  12. 4.4.4 Global Hirudin Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Hirudin Revenue by Manufacturers
  2. 5.1.1 Global Hirudin Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Hirudin Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Hirudin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Hirudin Sales by Manufacturers
  6. 5.2.1 Global Hirudin Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Hirudin Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Hirudin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Hirudin Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Hirudin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Hirudin Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Hirudin Manufacturers, Product Type & Application
  13. 5.7 Global Hirudin Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Hirudin Market CR5 and HHI
  16. 5.8.2 2025 Hirudin Tier 1, Tier 2, and Tier 3
6 Hirudin Market by Type
  1. 6.1 Global Hirudin Revenue by Type
  2. 6.1.1 Global Hirudin Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Hirudin Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Hirudin Sales by Type
  5. 6.2.1 Global Hirudin Sales by Type (2021-2032) & (MT)
  6. 6.2.2 Global Hirudin Sales Market Share by Type (2021-2032)
  7. 6.3 Global Hirudin Price by Type
7 Hirudin Market by Application
  1. 7.1 Global Hirudin Revenue by Application
  2. 7.1.1 Global Hirudin Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Hirudin Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Hirudin Sales by Application
  5. 7.2.1 Global Hirudin Sales by Application (2021-2032) & (MT)
  6. 7.2.2 Global Hirudin Sales Market Share by Application (2021-2032)
  7. 7.3 Global Hirudin Price by Application
8 Company Profiles
  1. 8.1 The Medicines Company
  2. 8.1.1 The Medicines Company Company Information
  3. 8.1.2 The Medicines Company Business Overview
  4. 8.1.3 The Medicines Company Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 The Medicines Company Hirudin Product Portfolio
  6. 8.1.5 The Medicines Company Recent Developments
  7. 8.2 Keyken
  8. 8.2.1 Keyken Company Information
  9. 8.2.2 Keyken Business Overview
  10. 8.2.3 Keyken Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Keyken Hirudin Product Portfolio
  12. 8.2.5 Keyken Recent Developments
  13. 8.3 Minapharm
  14. 8.3.1 Minapharm Company Information
  15. 8.3.2 Minapharm Business Overview
  16. 8.3.3 Minapharm Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Minapharm Hirudin Product Portfolio
  18. 8.3.5 Minapharm Recent Developments
  19. 8.4 Abbott
  20. 8.4.1 Abbott Company Information
  21. 8.4.2 Abbott Business Overview
  22. 8.4.3 Abbott Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Hirudin Product Portfolio
  24. 8.4.5 Abbott Recent Developments
  25. 8.5 SALUBRIS
  26. 8.5.1 SALUBRIS Company Information
  27. 8.5.2 SALUBRIS Business Overview
  28. 8.5.3 SALUBRIS Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 SALUBRIS Hirudin Product Portfolio
  30. 8.5.5 SALUBRIS Recent Developments
  31. 8.6 Pfizer, Inc
  32. 8.6.1 Pfizer, Inc Company Information
  33. 8.6.2 Pfizer, Inc Business Overview
  34. 8.6.3 Pfizer, Inc Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer, Inc Hirudin Product Portfolio
  36. 8.6.5 Pfizer, Inc Recent Developments
  37. 8.7 Teva Pharmaceutical Industries Ltd
  38. 8.7.1 Teva Pharmaceutical Industries Ltd Company Information
  39. 8.7.2 Teva Pharmaceutical Industries Ltd Business Overview
  40. 8.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceutical Industries Ltd Hirudin Product Portfolio
  42. 8.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
  43. 8.8 DUOPUTAI
  44. 8.8.1 DUOPUTAI Company Information
  45. 8.8.2 DUOPUTAI Business Overview
  46. 8.8.3 DUOPUTAI Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 DUOPUTAI Hirudin Product Portfolio
  48. 8.8.5 DUOPUTAI Recent Developments
  49. 8.9 Pentapharm
  50. 8.9.1 Pentapharm Company Information
  51. 8.9.2 Pentapharm Business Overview
  52. 8.9.3 Pentapharm Hirudin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Pentapharm Hirudin Product Portfolio
  54. 8.9.5 Pentapharm Recent Developments
9 North America
  1. 9.1 North America Hirudin Market Size by Type
  2. 9.1.1 North America Hirudin Revenue by Type (2021-2032)
  3. 9.1.2 North America Hirudin Sales by Type (2021-2032)
  4. 9.1.3 North America Hirudin Price by Type (2021-2032)
  5. 9.2 North America Hirudin Market Size by Application
  6. 9.2.1 North America Hirudin Revenue by Application (2021-2032)
  7. 9.2.2 North America Hirudin Sales by Application (2021-2032)
  8. 9.2.3 North America Hirudin Price by Application (2021-2032)
  9. 9.3 North America Hirudin Market Size by Country
  10. 9.3.1 North America Hirudin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Hirudin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Hirudin Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Hirudin Market Size by Type
  2. 10.1.1 Europe Hirudin Revenue by Type (2021-2032)
  3. 10.1.2 Europe Hirudin Sales by Type (2021-2032)
  4. 10.1.3 Europe Hirudin Price by Type (2021-2032)
  5. 10.2 Europe Hirudin Market Size by Application
  6. 10.2.1 Europe Hirudin Revenue by Application (2021-2032)
  7. 10.2.2 Europe Hirudin Sales by Application (2021-2032)
  8. 10.2.3 Europe Hirudin Price by Application (2021-2032)
  9. 10.3 Europe Hirudin Market Size by Country
  10. 10.3.1 Europe Hirudin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Hirudin Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Hirudin Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Hirudin Market Size by Type
  2. 11.1.1 China Hirudin Revenue by Type (2021-2032)
  3. 11.1.2 China Hirudin Sales by Type (2021-2032)
  4. 11.1.3 China Hirudin Price by Type (2021-2032)
  5. 11.2 China Hirudin Market Size by Application
  6. 11.2.1 China Hirudin Revenue by Application (2021-2032)
  7. 11.2.2 China Hirudin Sales by Application (2021-2032)
  8. 11.2.3 China Hirudin Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Hirudin Market Size by Type
  2. 12.1.1 Asia Hirudin Revenue by Type (2021-2032)
  3. 12.1.2 Asia Hirudin Sales by Type (2021-2032)
  4. 12.1.3 Asia Hirudin Price by Type (2021-2032)
  5. 12.2 Asia Hirudin Market Size by Application
  6. 12.2.1 Asia Hirudin Revenue by Application (2021-2032)
  7. 12.2.2 Asia Hirudin Sales by Application (2021-2032)
  8. 12.2.3 Asia Hirudin Price by Application (2021-2032)
  9. 12.3 Asia Hirudin Market Size by Country
  10. 12.3.1 Asia Hirudin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Hirudin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Hirudin Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Hirudin Market Size by Type
  2. 13.1.1 SAMEA Hirudin Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Hirudin Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Hirudin Price by Type (2021-2032)
  5. 13.2 SAMEA Hirudin Market Size by Application
  6. 13.2.1 SAMEA Hirudin Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Hirudin Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Hirudin Price by Application (2021-2032)
  9. 13.3 SAMEA Hirudin Market Size by Country
  10. 13.3.1 SAMEA Hirudin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Hirudin Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Hirudin Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Hirudin Value Chain Analysis
  2. 14.1.1 Hirudin Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Hirudin Production Mode & Process
  6. 14.2 Hirudin Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Hirudin Distributors
  9. 14.2.3 Hirudin Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst